Details of the Drug

General Information of Drug (ID: DMR6UL8)

• Drug Name: CT-064
• Synonyms: Ibandronate sodium monohydrate; 138926-19-9; Ibandronate sodium hydrate; UNII-J12U072QL0; Ibandronate (Sodium Monohydrate); J12U072QL0; Bondenza; sodium hydrate hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate; Monosodium [1-hydroxy-3-(methylpentylamino)propane-1,1-diyl]diphosphonate monohydrate; Destara; Ibandronate sodium [USAN:JAN]; hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate

Indication

Disease Entry	ICD 11	Status	REF
Osteoporosis	FB83.0	NDA filed	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C9H24NNaO8P2
  Canonical SMILES: CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]
  InChI: InChI=1S/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1
  InChIKey: VBDRTGFACFYFCT-UHFFFAOYSA-M
• Cross-matching ID:
  PubChem CID: 23663991
  CAS Number: 138926-19-9
  TTD ID: D0G9FL
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of Chugai Pharmaceutical.